iMedicus

Upcoming Live Programs

View All (3)

Quelles sont les considerations de traiter la coronopathie au-delà de l’AAS? Est-ce le temps d’établir un nouveau standard?

September 29, 2020

Colchicine: Une idée, des données probantes, un changement de pratique

September 30, 2020

Colchicine: Emerging Data and Impact on Clinical Practice

October 7, 2020

On-Demand

View All (20)

Managing the Elderly, Frail and Renal AF Patient: What we need to know

Dispelling Misperceptions in AF: Managing the challenges of renally impaired patients

Outils et technologies utiles en télémédecine pour le diagnostic et le suivi des patients avec FA durant la pandémie de COVID-19

Quelles sont les considerations de traiter la coronopathie au-delà de l'AAS? Est-ce le temps d'établir un nouveau standard?

Dispelling myths in AF: Managing the challenges of elderly, frail and/or renally impaired patients

An Approach to the Treatment of AF and CV Disease in These Challenging Times

How to Reduce the Risk of Major Cardiovascular and Limb Events in the CAD + PAD Patients

Prise en charge virtuelle des patients atteints de maladies cardiovasculaires pendant la pandémie de COVID

Hot Topics in Vascular Protection for the CAD Patient and AF Patient

Virtual Management of Patients with AF and CV Disease During the COVID Pandemic

Breaking News: A Canadian perspective from ACC 2020

How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient

How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient

Les NACO chez les patients âgés et vulnérables : Que devrions-nous savoir?

February 13, 2020

Optimizing Heart Failure Therapy - The Time is Now: Putting Evidence into Practice

December 5, 2019

Deconstructing Cardiovascular Outcomes for Patients with Diabetes

December 5, 2019

Diabetes Mobile Apps: Benefits for Patients and Healthcare Professionals

November 13, 2019

The Evolving Landscape of Cutaneous Squamous Cell Carcinoma Treatment: Updates on Immunotherapy Treatment

October 30, 2019

15 min. Highlights from The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients?

October 26, 2019

Women and CV Disease: Closing Care Gaps & Assessing Risk

Breaking News Series

View All (1)

Breaking News: A Canadian perspective from ACC 2020